Edward G Barrett
Overview
Explore the profile of Edward G Barrett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colvin K, Elliott R, Goodman D, Harral J, Barrett E, Yeager M
FASEB Bioadv
. 2023 Dec;
5(12):528-540.
PMID: 38094158
Objectives: We sought to investigate whether the Dp16 mouse model of Down syndrome (DS) is more susceptible to severe and lethal respiratory tract infection by . Study Design: We infected...
2.
Kuehl P, Dearing J, Werts A, Cox J, Irshad H, Barrett E, et al.
Microbiol Spectr
. 2023 Oct;
11(6):e0471722.
PMID: 37882564
The main route of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is airborne. However, there are few experimental systems that can assess the airborne transmission dynamics of SARS-CoV-2 ....
3.
Barrett E, Revelli D, Bakshi C, Kadish A, Amar S
Front Microbiol
. 2023 Jun;
14:1212179.
PMID: 37293233
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has resulted in over 6.7 million deaths worldwide. COVID-19 vaccines administered parenterally via intramuscular or subcutaneous (SC) routes have reduced the severity...
4.
Khanna K, Raymond W, Jin J, Charbit A, Gitlin I, Tang M, et al.
Am J Physiol Lung Cell Mol Physiol
. 2022 Jun;
323(3):L372-L389.
PMID: 35762590
The redox status of the cysteine-rich SARS-CoV-2 spike glycoprotein (SARS-2-S) is important for the binding of SARS-2-S to angiotensin-converting enzyme 2 (ACE2), suggesting that drugs with a functional thiol group...
5.
Langel S, Johnson S, Martinez C, Tedjakusuma S, Peinovich N, Dora E, et al.
Sci Transl Med
. 2022 May;
14(658):eabn6868.
PMID: 35511920
Transmission-blocking strategies that slow the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect against coronavirus disease 2019 (COVID-19) are needed. We have developed an orally delivered adenovirus...
6.
Khanna K, Raymond W, Jin J, Charbit A, Gitlin I, Tang M, et al.
bioRxiv
. 2020 Dec;
PMID: 33330868
Neutrophil-induced oxidative stress is a mechanism of lung injury in COVID-19, and drugs with a functional thiol group ("thiol drugs"), especially cysteamine, have anti-oxidant and anti-inflammatory properties that could limit...
7.
Mastrangelo P, Norris M, Duan W, Barrett E, Moraes T, Hegele R
Vaccines (Basel)
. 2017 Sep;
5(3).
PMID: 28925950
Nucleolin (NCL) has been reported as a cellular receptor for the human respiratory syncytial virus (RSV). We studied the effects of re-purposing AS1411, an anti-cancer compound that binds cell surface...
8.
Youngren-Ortiz S, Hill D, Hoffmann P, Morris K, Barrett E, Gregory Forest M, et al.
J Aerosol Med Pulm Drug Deliv
. 2017 Mar;
30(5):299-321.
PMID: 28277892
Background: Aerosol delivery of chemotherapeutic nanocarriers represents a promising alternative for lung cancer therapy. This study optimized gemcitabine (Gem)-loaded gelatin nanocarriers (GNCs) cross-linked with genipin (Gem-GNCs) to evaluate their potential...
9.
Goehring K, Marriage B, Oliver J, Wilder J, Barrett E, Buck R
J Nutr
. 2016 Nov;
146(12):2559-2566.
PMID: 27798337
Background: Evidence suggests that human milk oligosaccharides (HMOs) provide multiple benefits to infants, including prebiotic effects, gut maturation, antimicrobial activities, and immune modulation. Clinical intervention studies with HMOs are required...
10.
Davis P, Giannini G, Rudolph K, Calloway N, Royer C, Beckett T, et al.
Neurobiol Aging
. 2016 Oct;
49:86-99.
PMID: 27776266
Beta-amyloid (Aβ) immunotherapy is a promising intervention to slow Alzheimer's disease. Aging dogs naturally accumulate Aβ and show cognitive decline. An active vaccine against fibrillar Aβ 1-42 (VAC) in aged...